Paul G. Richardson, MD, summarizes novel agents and combinations used for treating multiple myeloma. Key strategies include targeting protein degradation, restoring immune function, and combination therapy. Learn more about treatment for multiple myeloma at Dana-Farber. [ Ссылка ]
View more presentations from the 2017 Multiple Myeloma patient Education Symposium at Dana-Farber Cancer Institute. [ Ссылка ]

свернуть